Search
Home
News
Fortune 500
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Great Place To Work
Tech
AI
Innovation
Cybersecurity
Finance
Personal Finance
Real Estate
Economy
Investing
Banking
Crypto
Leadership
Success
Future Of Work
Workplace Culture
C-Suite
CEO Initiative
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Analytics
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Home
News
Fortune 500
Fortune 500
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Great Place To Work
Tech
Tech
AI
Innovation
Cybersecurity
Finance
Finance
Personal Finance
Real Estate
Economy
Investing
Banking
Crypto
Leadership
Leadership
Success
Future Of Work
Workplace Culture
C-Suite
CEO Initiative
Lifestyle
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Rankings
Analytics
Multimedia
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Asia
Europe
Analytics
home
home
Roivant Sciences
Roivant Sciences
Health
How a 32-Year-Old CEO Got a Team of Pharma Vets to Join His Radical Approach to Making Drugs
By
Sy Mukherjee
September 21, 2017
Health
Why SoftBank Made a Record-Breaking $1.1 Billion Bet on This Biotech Firm
By
Sy Mukherjee
August 9, 2017
Health
This 31-Year-Old CEO Is Snapping Up Drug Industry Veterans Left and Right
By
Sy Mukherjee
July 10, 2017
Health
This 31-Year-Old Just Launched His 5th Biotech Company With a Boost From Merck
By
Sy Mukherjee
June 6, 2017
Most Popular
AI
Russia's first AI-powered robot walked on stage to triumphant music, took a few steps, and then immediately faceplanted
By
Dave Smith
Real Estate
This 38-year-old used to be homeless and now pays $19 per month for an apartment over an LA subway station thanks to...
By
Michael Casey
and
The Associated Press
Success
This ‘hidden’ career path is in dire need of more workers—and it can pay Gen Z over $300,000 with no degree required
By
Preston Fore
